482 related articles for article (PubMed ID: 25483508)
21. Dendritic cell-based immunotherapy.
Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
[TBL] [Abstract][Full Text] [Related]
22. Current perspectives on immunotherapy.
Weber JS
Semin Oncol; 2014 Oct; 41 Suppl 5():S14-29. PubMed ID: 25438996
[TBL] [Abstract][Full Text] [Related]
23. Cancer vaccines: translation from mice to human clinical trials.
Maeng H; Terabe M; Berzofsky JA
Curr Opin Immunol; 2018 Apr; 51():111-122. PubMed ID: 29554495
[TBL] [Abstract][Full Text] [Related]
24. Vaccines: an innovative approach to treating cancer.
Pazdur MP; Jones JL
J Infus Nurs; 2007; 30(3):173-8. PubMed ID: 17505219
[TBL] [Abstract][Full Text] [Related]
25. Clinical cancer vaccine trials.
Jäger E; Jäger D; Knuth A
Curr Opin Immunol; 2002 Apr; 14(2):178-82. PubMed ID: 11869889
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic cancer vaccines: From initial findings to prospects.
Song Q; Zhang CD; Wu XH
Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
[TBL] [Abstract][Full Text] [Related]
27. Tumor antigens as surrogate markers and targets for therapy and vaccines.
Dalgleish A; Pandha H
Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
[TBL] [Abstract][Full Text] [Related]
28. Cancer vaccines and immunotherapy.
Tang H
Hum Vaccin; 2009 Oct; 5(10):666. PubMed ID: 19855174
[No Abstract] [Full Text] [Related]
29. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
30. Antigens for cancer immunotherapy.
Neller MA; López JA; Schmidt CW
Semin Immunol; 2008 Oct; 20(5):286-95. PubMed ID: 18951039
[TBL] [Abstract][Full Text] [Related]
31. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
32. Antigen-specific immunotherapy and cancer vaccines.
Jäger E; Jäger D; Knuth A
Int J Cancer; 2003 Oct; 106(6):817-20. PubMed ID: 12918057
[TBL] [Abstract][Full Text] [Related]
33. [Current status and future perspective of cancer vaccine development].
Sasada T; Itoh K
Gan To Kagaku Ryoho; 2011 Apr; 38(4):503-8. PubMed ID: 21498975
[TBL] [Abstract][Full Text] [Related]
34. Personalized Cancer Vaccines Advance in the Clinic.
Schmidt C
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29095978
[No Abstract] [Full Text] [Related]
35. Current developments in cancer vaccines and cellular immunotherapy.
Ribas A; Butterfield LH; Glaspy JA; Economou JS
J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
[TBL] [Abstract][Full Text] [Related]
36. Cancer vaccines: a critical review on clinical impact.
Bitton RJ
Curr Opin Mol Ther; 2004 Feb; 6(1):17-26. PubMed ID: 15011777
[TBL] [Abstract][Full Text] [Related]
37. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
38. Vaccine immunotherapy for cancer.
Bridgewater J; Collins M
Mol Cell Biol Hum Dis Ser; 1995; 5():140-56. PubMed ID: 9532565
[No Abstract] [Full Text] [Related]
39. Overview of tumor cell-based vaccines.
Copier J; Dalgleish A
Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778
[TBL] [Abstract][Full Text] [Related]
40. Vaccines in leukemia.
Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]